Compare FND & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FND | TWST |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.2B |
| IPO Year | 2014 | 2018 |
| Metric | FND | TWST |
|---|---|---|
| Price | $62.69 | $115.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $73.44 | $46.88 |
| AVG Volume (30 Days) | ★ 2.5M | 1.4M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.05 | ★ 63.89 |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $4,684,088,000.00 | $376,572,000.00 |
| Revenue This Year | $7.53 | $18.91 |
| Revenue Next Year | $7.68 | $15.07 |
| P/E Ratio | $47.99 | ★ N/A |
| Revenue Growth | 5.12 | ★ 20.32 |
| 52 Week Low | $42.64 | $23.30 |
| 52 Week High | $92.41 | $115.56 |
| Indicator | FND | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 63.74 |
| Support Level | $58.85 | $42.88 |
| Resistance Level | $60.04 | N/A |
| Average True Range (ATR) | 2.64 | 8.13 |
| MACD | 0.54 | 1.68 |
| Stochastic Oscillator | 72.64 | 81.47 |
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.